Aurora Cannabis: EBITDA targets will be difficult to achieve

What Aurora has to do in terms of sales and expenses in order to produce that level of EBITDA will be tough given its current cost structure, consumers trending to value brands, the Canadian market’s excess inventory and continued production overcapacity of Canadian licensed producers.  

Harvest execs surrender stock options for reprice, redistribution

Three key executives at Harvest Health will surrender a total of 2.4 million stock options back to the company – without compensation – so the options can be redistributed to employees throughout the company. It’s a novel concept, but common equity holders will still be diluted.